DENTSPLY SIRONA - XRAY Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" XRAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View XRAY analyst ratings or view top-rated stocks.

9 brokers have issued 12 month price objectives for DENTSPLY SIRONA's shares. Their XRAY share price forecasts range from $38.00 to $67.00. On average, they expect the company's share price to reach $48.11 in the next twelve months. This suggests a possible upside of 27.8% from the stock's current price.
View analysts price targets for XRAY or view top-rated stocks among Wall Street analysts.

DENTSPLY SIRONA's stock was trading at $55.79 at the beginning of 2022. Since then, XRAY stock has decreased by 32.5% and is now trading at $37.65.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 18th 2022.
View our XRAY earnings forecast.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) issued its quarterly earnings data on Thursday, November, 4th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.65 by $0.03. The medical instruments supplier earned $1.07 billion during the quarter, compared to analysts' expectations of $1.02 billion. DENTSPLY SIRONA had a net margin of 8.81% and a trailing twelve-month return on equity of 11.63%. DENTSPLY SIRONA's revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.67 earnings per share.
Read the conference call transcript.

DENTSPLY SIRONA announced a quarterly dividend on Thursday, August 4th. Investors of record on Friday, September 30th will be given a dividend of $0.125 per share on Friday, October 14th. This represents a $0.50 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Thursday, September 29th.
Read our dividend analysis for XRAY.

DENTSPLY SIRONA (NASDAQ:XRAY) pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.33%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 29.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, XRAY will have a dividend payout ratio of 18.94% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for XRAY.

DENTSPLY SIRONA issued an update on its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share (EPS) guidance of $2.35-$2.55 for the period, compared to the consensus estimate of $2.77. The company issued revenue guidance of $4.10 billion-$4.20 billion, compared to the consensus revenue estimate of $4.23 billion.

105 employees have rated DENTSPLY SIRONA Chief Executive Officer Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA's stock is owned by a number of retail and institutional investors. Top institutional investors include Artisan Partners Limited Partnership (5.92%), Nuance Investments LLC (4.20%), Cooke & Bieler LP (2.19%), Mackenzie Financial Corp (1.90%), Massachusetts Financial Services Co. MA (1.43%) and Northern Trust Corp (1.21%). Insiders that own company stock include Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Lisa Yankie, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XRAY stock can currently be purchased for approximately $37.65.

DENTSPLY SIRONA (NASDAQ:XRAY) has a market capitalization of $8.11 billion and generates $4.25 billion in revenue each year. The medical instruments supplier earns $421 million in net income (profit) each year or $1.69 on an earnings per share basis.

The company employs 15,000 workers across the globe.

DENTSPLY SIRONA was founded in 2016.

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The official website for the company is www.dentsplysirona.com. The medical instruments supplier can be reached via phone at (844) 848-0137, via email at john.sweeney@dentsplysirona.com, or via fax at 302-655-5049.